ESTIMATION OF CLINICAL EFFICIENCY OF OMACOR AND SIMVASTOL AT PATIENTS OF THE IHD WITH DYSLIPIDEMIA AND ARRHYTHMIA
The paper deals with the treatment of patients with IHD with lipid disorders and arrhythmia drugs as polyunsaturated fatty acids and statins. Various variants of dyslipidemia at patients of IHD are revealed. Are defined hypolipidemic effects of omacor and simvastol at correction isolated and combined hypercholesterolemia, and also isolated hypertriglyceridemia. Daily monitoring of an electrocardiogram is spent, various infringements of a rhythm have been revealed. The analysis of the effectiveness of omacor and simvastol in patients with isolated and combined hypercholesterolemia, as well as the isolated and combined hypertriglyceridemia. Implemented neural network prediction of the effectiveness of the studied drugs in patients with lipid metabolism disodress. The analysis of efficiency of omacor is carried out at correction ventricular and supraventricular extrasystole. The cohort of patients for which use of omacor for hypolipidemic and antiarrhytmic correction is revealed is most justified.